富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/01 | 1,362 | 1,366 | 1,351 | 1,357 | -9 | -0.7% | 23,500 |
| 2025/04/30 | 1,375 | 1,375 | 1,357 | 1,366 | -4 | -0.3% | 22,800 |
| 2025/04/28 | 1,355 | 1,381 | 1,355 | 1,370 | +15 | +1.1% | 23,500 |
| 2025/04/25 | 1,355 | 1,370 | 1,355 | 1,355 | ±0 | ±0% | 24,300 |
| 2025/04/24 | 1,368 | 1,371 | 1,354 | 1,355 | -7 | -0.5% | 25,300 |
| 2025/04/23 | 1,353 | 1,370 | 1,347 | 1,362 | +10 | +0.7% | 33,600 |
| 2025/04/22 | 1,342 | 1,355 | 1,335 | 1,352 | +22 | +1.7% | 31,000 |
| 2025/04/21 | 1,326 | 1,332 | 1,314 | 1,330 | -8 | -0.6% | 20,300 |
| 2025/04/18 | 1,322 | 1,340 | 1,308 | 1,338 | +35 | +2.7% | 36,500 |
| 2025/04/17 | 1,314 | 1,315 | 1,295 | 1,303 | -14 | -1.1% | 29,500 |
| 2025/04/16 | 1,337 | 1,341 | 1,309 | 1,317 | ±0 | ±0% | 39,100 |
| 2025/04/15 | 1,301 | 1,321 | 1,301 | 1,317 | +22 | +1.7% | 32,100 |
| 2025/04/14 | 1,292 | 1,309 | 1,285 | 1,295 | +27 | +2.1% | 42,800 |
| 2025/04/11 | 1,257 | 1,276 | 1,238 | 1,268 | -38 | -2.9% | 66,100 |
| 2025/04/10 | 1,315 | 1,320 | 1,290 | 1,306 | +50 | +4% | 61,500 |
| 2025/04/09 | 1,232 | 1,270 | 1,232 | 1,256 | +7 | +0.6% | 159,900 |
| 2025/04/08 | 1,241 | 1,249 | 1,206 | 1,249 | +68 | +5.8% | 102,900 |
| 2025/04/07 | 1,193 | 1,225 | 1,180 | 1,181 | -72 | -5.7% | 147,600 |
| 2025/04/04 | 1,283 | 1,283 | 1,229 | 1,253 | -42 | -3.2% | 132,900 |
| 2025/04/03 | 1,261 | 1,301 | 1,261 | 1,295 | -20 | -1.5% | 66,600 |
| 2025/04/02 | 1,346 | 1,346 | 1,313 | 1,315 | -22 | -1.6% | 55,800 |
| 2025/04/01 | 1,343 | 1,356 | 1,337 | 1,337 | +1 | +0.1% | 42,600 |
| 2025/03/31 | 1,378 | 1,378 | 1,331 | 1,336 | -53 | -3.8% | 79,600 |
| 2025/03/28 | 1,399 | 1,404 | 1,385 | 1,389 | -30 | -2.1% | 47,100 |
| 2025/03/27 | 1,408 | 1,419 | 1,396 | 1,419 | +7 | +0.5% | 60,000 |
| 2025/03/26 | 1,400 | 1,414 | 1,398 | 1,412 | +15 | +1.1% | 54,300 |
| 2025/03/25 | 1,389 | 1,399 | 1,383 | 1,397 | +3 | +0.2% | 40,700 |
| 2025/03/24 | 1,410 | 1,410 | 1,383 | 1,394 | -8 | -0.6% | 52,500 |
| 2025/03/21 | 1,399 | 1,402 | 1,388 | 1,402 | +3 | +0.2% | 43,800 |
| 2025/03/19 | 1,384 | 1,405 | 1,376 | 1,399 | +26 | +1.9% | 52,600 |
| 2025/03/18 | 1,365 | 1,384 | 1,365 | 1,373 | +9 | +0.7% | 47,600 |
| 2025/03/17 | 1,362 | 1,368 | 1,352 | 1,364 | +12 | +0.9% | 39,300 |
| 2025/03/14 | 1,350 | 1,359 | 1,346 | 1,352 | -4 | -0.3% | 40,900 |
| 2025/03/13 | 1,344 | 1,361 | 1,343 | 1,356 | +12 | +0.9% | 50,300 |
| 2025/03/12 | 1,342 | 1,344 | 1,334 | 1,344 | +1 | +0.1% | 32,800 |
| 2025/03/11 | 1,340 | 1,344 | 1,327 | 1,343 | -3 | -0.2% | 42,000 |
| 2025/03/10 | 1,364 | 1,364 | 1,340 | 1,346 | -9 | -0.7% | 37,900 |
| 2025/03/07 | 1,330 | 1,355 | 1,303 | 1,355 | +13 | +1% | 121,800 |
| 2025/03/06 | 1,354 | 1,361 | 1,335 | 1,342 | +2 | +0.1% | 57,200 |
| 2025/03/05 | 1,348 | 1,353 | 1,336 | 1,340 | -8 | -0.6% | 74,400 |
| 2025/03/04 | 1,362 | 1,362 | 1,320 | 1,348 | -18 | -1.3% | 140,100 |
| 2025/03/03 | 1,353 | 1,366 | 1,348 | 1,366 | +22 | +1.6% | 45,400 |
| 2025/02/28 | 1,352 | 1,354 | 1,335 | 1,344 | -10 | -0.7% | 56,100 |
| 2025/02/27 | 1,341 | 1,354 | 1,332 | 1,354 | +13 | +1% | 59,100 |
| 2025/02/26 | 1,354 | 1,364 | 1,332 | 1,341 | -13 | -1% | 61,100 |
| 2025/02/25 | 1,327 | 1,357 | 1,327 | 1,354 | +23 | +1.7% | 55,500 |
| 2025/02/21 | 1,342 | 1,349 | 1,328 | 1,331 | -17 | -1.3% | 76,800 |
| 2025/02/20 | 1,378 | 1,378 | 1,336 | 1,348 | -35 | -2.5% | 135,900 |
| 2025/02/19 | 1,378 | 1,396 | 1,378 | 1,383 | +3 | +0.2% | 59,000 |
| 2025/02/18 | 1,355 | 1,381 | 1,354 | 1,380 | +19 | +1.4% | 55,600 |
1～
50
件表示中 / 6944件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 135,700円 | +15.7% | +5.3% | 3.35% | 9.81倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| タウンズ | 50,500円 | +4.6% | +6.1% | 5.54% | 8.59倍 | 3.18倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 生化学 | 70,400円 | +9.2% | +39.0% | 4.26% | 23.29倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,000円 | +150.0% | - | 0.00% | - | 15.74倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 208,000円 | +4.5% | -33.7% | 3.37% | 20.95倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
市場注目の銘柄
チャート関連のコラム
